Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.

The enterprise value of the transaction is SEK 500 million, with potential for an additional earnout of up to SEK 130 million. Up to SEK 100 million of the purchase price can be paid in Aspo shares.

Aspo is a Finnish conglomerate that specializes in demanding B-to-B customers. Aspo creates value by owning and developing business operations sustainably and in the long term. Aspo has businesses in 16 different countries, and it employs a total of approximately 700 professionals.

Read the client’s press release here.

Vinge’s team mainly consisted of Jonas Johansson, Linus Adolfsson, Tim Axell (M&A), Karl-Gustaw Tobola (Banking and Finance), Mario Saad (Corporate Commercial), Ebba Svenburg, Jonna Skog (Employment) Johan Cederblad, Lina Österberg (Environment), Elis Almark, Carla Zachariasson (IT & GDPR), Karolina Cohrs (Real Estate), Daniel Wendelsson, Sebastian Örndahl, Dagne Sabockis, Hilda Ivarsson (FDI, EU, Competition and Regulatory) and Emma Emsjö (Transaction Support Coordinator).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025